Last updated on January 4, 2023 by
Roche: Doing What Patients Need Next
Edward Teller once said, “The science of today is the technology of tomorrow.”
This ideology inspires several biomedical and biotechnology researchers to create effective and advanced solutions for critical diseases and health crises.
This understanding of current and future needs for medical innovations is what makes Roche a world leader in the biotech market.
Roche invests around 9 billion Swiss francs (CHF) in Research and Development every year—the highest among what is spent by other healthcare companies. This shows the passion and commitment of the company in transforming people’s lives.
F. Hoffmann-La Roche & Co. was founded by Fritz Hoffmann-La Roche in 1896 in Basel, Switzerland. The company strengthened its foundation and spread its roots into research and innovation through acquisitions of companies like Genentech and Chugai Pharmaceuticals.
Currently, the company is led by Severin Schwan (Chief Executive Officer) and its other key players, including Christoph Franz (Chairman), André Hoffmann (Vice-Chairman), William N. (Bill) Anderson (CEO Roche Pharmaceuticals), and Thomas Schinecker (CEO Roche Diagnostics).
The company that started with simple thyroid and antiseptic preparations is now making an impact in four other branches: Pharmaceuticals, Vitamins and Fine Chemicals, Diagnostics, and Flavors and Fragrances.
This article presents Roche’s product portfolio and its applications in biomedical areas. Further, you will also learn about its ongoing innovations and its commitment to sustainability.
If your lab or clinic is working on a budget, our lease program can help you get the technology and equipment it deserves. Get your customized leasing solution now.
Roche’s Product Portfolio
Roche is a leading pharma and healthcare company providing effective solutions for critical disease areas such as oncology, infectious diseases, immunology, as well as neuroscience and rare diseases. Its range of products includes improved drugs, diagnostic tests, and services with significant benefits over existing options.
Roche has brought many highly effective drugs to market that tackle some of the world’s most formidable healthcare challenges. More than 90 countries have approved at least one of its products that fight life-threatening diseases.
A few examples of drugs produced by Roche include:
- Alecensa: The drug is approved in 116 countries for the treatment of rheumatoid arthritis.
- CellCept: An immunosuppressant that is used to prevent organ transplant rejection.
- Fuzeon: A critical HIV fusion inhibitor used to treat HIV-infected patients.
- Herceptin (trastuzumab): Herceptin is a monoclonal antibody that binds to the HER2 receptor to hinder its growth-signaling events. It’s the first HER2-targeted therapy for breast cancer.
- Gazyva/Gazyvaro (obinutuzumab): An approved drug for the treatment of chronic lymphocytic leukemia.
- Avastin (bevacizumab): Avastin is used in several cancer treatments, including colorectal, ovarian, cervical, lung, and kidney cancers.
- Accu-chek brands: This category has A-to-Z solutions for diabetes management.
Solutions for Diagnostics
Roche offers a wide range of rapid, reliable instruments and tests for disease screening and diagnosis in laboratories. The products serve the entire healthcare spectrum, from hospitals, patients, and physicians, to commercial laboratories and various research institutions.
Roche is also contributing to the COVID-19 pandemic by creating effective research and diagnostic solutions. Its product, the Cobas® SARS-CoV-2 Test, which received approval in 2020, is used to detect the novel coronavirus disease that causes the SARS-CoV-2 virus.
Given below is a list of healthcare areas supported by Roche’s diagnostic products:
- Centralized and Point of Care Solutions
- Diabetes Care
- Diagnostics Information Solutions
- Molecular Diagnostics & Research
- Solution Integration and Services
- Tissue Diagnostics & Research
- Hospital & Laboratory Analytics
Products for Researchers
Roche supports researchers in their pursuit of discovery by developing and providing a broad array of instruments and reagents they rely on each day. Its wide range of services includes custom-designed assays, nucleic acid purification, PCR solutions, and publication databases.
Roche divides its products into three distinct categories as follows:
- MagNA Pure Systems
- LightCycler Systems
- Reagents and Consumables
- Nucleic Acid Purification
- Real-time PCR
- Reverse Transcription
- Probes/Universal Probe/Library
- Single Assays
- Custom Panels
- Modular Assays
Learn more about Roche’s product portfolio and applications at www.roche.com.
Research & Development: What is Roche Working On?
Diseases like cancer don’t fit into the idea of “one-size-fits-all products.” The difficulty of treating diseases can be understood by this case: If two people suffering from the same disease are given the same treatment, there is a possibility that one of them responds well to the treatment and the other does not.
This emphasizes how important it is to understand the different responses patients have and the factors behind those responses. These problems can be tackled through innovative, personalized medicine solutions.
At Roche, personalized healthcare is central to its business strategy. Its scientists are working towards a unique understanding of human biology by utilizing new ways to analyze health data. Its vision is to transform the future of healthcare by tailoring the right treatment for the right patient at the right time.
Here’s a list of biomedical areas where Roche is working on developing personalized medicines:
- Cardiovascular and metabolism
- Research Technologies
- Infectious Diseases
- Inflammatory Bowel Diseases
- Neuroscience and Rare Diseases
Roche’s Commitment to Sustainability
Sustainability means both providing accessible, quality healthcare to patients and improving patient outcomes while measuring those results against environmental and social impacts in order to create a more sustainable health service for all. Not just today but for the future as well.
Sustainability is at the core of Roche. It offers products and services that address unmet medical needs and are of real value to society. It’s working towards finding equitable and sustainable solutions for challenges, including access to medical innovations and quality healthcare, the differences in accessible medical care worldwide, and the lack of effective disease infrastructures.
Roche’s goal is to manufacture standardized and safer medicines and make them available to the world. It supports perseverance and long-term thinking to create long-term value and lasting innovation for a better society.
Image: An illustration of Roche’s contribution to society through its sustainable products and services.
Don’t have the budget to purchase lab equipment outright? Consider leasing through Excedr to save your lab time and money. Browse your leasing options today.
Save Money and Accelerate R&D With Excedr
Roche is a pioneer in cancer biology and personalized treatments, helping thousands and millions of patients live better lives.
It’s working towards creating and supplying sustainable products and services that contribute to the betterment of today’s society and the future. It has a range of products critically falling into two categories of pharmaceuticals and diagnostics. It’s also helping researchers by providing them cutting-edge technologies for their breakthroughs.
But what if you’re operating a lab on a tight budget and can’t afford to tie up your cash reserves?
Excedr supports labs by providing the best customized lease programs for unhindered, affordable research.
Contact one of our leasing reps today to get a customized solution for your lab!